Clearance Summary
VBL SERUM TROPONIN I TEST, MODEL 1001 received FDA 510(k) clearance under submission number K023505, sponsored by Vancouver Biotech , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2003-03-31.
- Submission: K023505
- Applicant / Sponsor: Vancouver Biotech , Ltd.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1215
- Decision date: 2003-03-31
Classification & Regulation
This clearance is catalogued under FDA product code MMI and 21 CFR 862.1215, within the Clinical Chemistry review panel as a Class II device.